Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis

Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis

Bibliographic Details
Main Author:	Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2014-11-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	hepatitis chronic; interferon-alpha; guidebooks
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=6107&ClassID=101792734

Similar Items

Expert consenus on antiviral therapy for special patients with chronic hepatitis B: an update in 2014
by: Committee of experts on antiviral therapy for special patients with chronic hepatitis B
Published: (2014-07-01)

Chinese consensus on pancreatic cancer diagnosis and treatment (2014 version)
by: The Chinese Society of Clinical Oncology Pancreatic Cancer Expert Committee
Published: (2014-12-01)

Diagnosis and treatment of cholangiocarcinoma: surgical expert consensus
by: Chinese Chapter of International Hepato-Pancreato-Biliary Association，Hepatic Surgery Group, Chinese Society of Surgery, Chinese Medical Association.
Published: (2015-01-01)

Expert consensus on antiviral therapy for special patients with chronic hepatitis B: an update in 2015
by: Expert Committee for Antiviral Therapy for Special Patients with Chronic Hepatitis B
Published: (2015-08-01)

Strategy and method of multi-disciplinary comprehensive treatment of liver cancer-consensus of experts in Guangdong, China (2)
by: Society of Liver Cancer, Guangdong Provincial Anti-cancer Association.
Published: (2014-11-01)

Interpretation of Radiotherapy Document in Chinese Expert Consensus on Comprehensive Diagnosis and Treatment of Pancreatic Cancer (2014 Edition)
by: REN Gang
Published: (2014-12-01)

Explanation of the “Expert consensus on antiviral therapy to hepatitis B/C virus-related hepatocellular carcinoma”
by: DONG Jing
Published: (2014-07-01)

Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application
by: Francesco Roselli, et al.
Published: (2018-06-01)

Establishment of multi-disciplinary team for comprehensive treatment of liver cancer - consensus of experts in Guangdong, China (1)
by: Society of Liver Cancer, Guangdong Provincial Anti-cancer Association.
Published: (2014-11-01)

Expert interpretation of the “KASL Clinical Practice Guidelines: Management of hepatitis C”
by: DING Yang
Published: (2015-01-01)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
by: Megen C. Wittling, et al.
Published: (2021-01-01)

Long-term treatment of chronic hepatitis B
by: Experts attending the discussion on long-treatment of chronic hepatitis B
Published: (2014-11-01)

Characterization of murine interferon alpha 12 (MuIFN α12): biological activities and gene regulation.
Published: (2005)

Molecular analysis of interferon-alpha subtypes and their expression profiles in the viral infected cells.
Published: (2002)

Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)

Chinese consensus on the medical diagnosis and treatment of chronic cholecystitis and gallstones (2014, Shanghai)
by: Editorial Board of Chinese Journal of Digestion
Published: (2015-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01)

Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis Estudo dos auto-anticorpos nas Hepatites virais crônicas B e C antes, durante e após tratamento com Interferon-alfa
by: Edmundo P.A. Lopes, et al.
Published: (1995-10-01)

Expert consensus on clinical application of entecavir: an update in 2015
by: Expert Committee for Clinical Application of Entecavir
Published: (2016-01-01)

Significance of the interferon (IFN) in the therapy
by: Sabina Mahmutović, et al.
Published: (2004-11-01)

Insights Into Type I and III Interferons in Asthma and Exacerbations
by: Helen E. Rich, et al.
Published: (2020-09-01)

Effects of interferon therapy onfunctional activity of platelets in chronic viral hepatitis andcirrhosis of the liver
by: A V Yagoda, et al.
Published: (2004-08-01)

Autoanticuerpos en pacientes hematológicos tratados con interferón alfa
by: Antonio A Bencomo Hernández, et al.

POSSIBILITIES OF REPLACEMENT INTERFERON THERAPY TO TREAT ATOPIC DERMATITIS IN IMMUNOCOMPROMISED PATIENTS
by: L. P. Sizyakina, et al.
Published: (2017-07-01)

欧洲肝病学会临床实践指南：HCV感染的管理（推荐意见）
by: ZHU Peng
Published: (2014-02-01)

Chinese guidelines for the management of acute pancreatitis (Shanghai, 2013)
by: Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion
Published: (2013-09-01)

Norms and clinical interpretation guidelines from the Hepatology Branch of the Chinese Medical Association
by: CHEN Xiaoping
Published: (2013-01-01)

Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
by: Stanojević Ivan, et al.
Published: (2015-01-01)

Tratamento de hemangioma gigante com interferon alfa: relato de dois casos Treatment of giant hemangioma with interferon-alpha: report of two cases
by: Ana Julia Balau, et al.
Published: (2007-12-01)

Individualized treatment with pegylated interferon-α for chronic hepatitis B
by: WAN Mobin
Published: (2018-05-01)

Evaluating the Efficacy of Interferon Preparations in the Treatment of Acute Respiratory Viral Infections in Sickly Children
by: L.V. Besh
Published: (2015-03-01)

Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study
by: Łukasz Obołończyk, et al.
Published: (2017-09-01)

Are anti-interferon antibodies the cause of failure in: chronic HCV hepatitis treatment?
by: Antonio Alci Barone, et al.

Ciblage de l'activité de l'interféron alpha : de la preuve de concept à l'activité biologique
by: Paul, Franciane
Published: (2016)

The value of interferon therapy for COVID-19 in children
by: L. N. Mazankova, et al.
Published: (2021-04-01)

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
by: Ji Hwan Lee, et al.
Published: (2018-02-01)

Flaxseed Prevents Interferon-alpha Induced Depressive Behavior in Mice: the α-Linolenic Acid is Essential
by: Azadeh Mesripour*, et al.
Published: (2021-01-01)

Impact of pegylated interferon versus conventional interferon on the change in peripheral CD4+CD25high T cells in patients with chronic hepatitis B
by: WANG Haiyan
Published: (2018-01-01)

Effect of interferon-alpha on experimental septal fibrosis of the liver - study with a new model
by: Marcia Maria de Souza, et al.
Published: (2001-04-01)

Ocular changes due to systemic alpha-interferon therapy for hepatitis C Alterações oculares por uso sistêmico de alfa-interferon em pacientes com hepatite C
by: Liang Shih Jung, et al.
Published: (2004-12-01)